T. Kennedy

436 total citations
13 papers, 329 citations indexed

About

T. Kennedy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, T. Kennedy has authored 13 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Otorhinolaryngology. Recurrent topics in T. Kennedy's work include Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Parasitic Infections and Diagnostics (3 papers). T. Kennedy is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Parasitic Infections and Diagnostics (3 papers). T. Kennedy collaborates with scholars based in United States and Denmark. T. Kennedy's co-authors include Howard Safran, Wallace Akerley, H. Choy, Bernard F. Cole, Christine H. Chung, Todd Williams, Stephen L. Graziano, Martin Furr, H. J. Wanebo and Frank M. Andrews and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgical Oncology and Veterinary Parasitology.

In The Last Decade

T. Kennedy

11 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Kennedy United States 6 186 121 91 67 49 13 329
Hui Yuan China 7 38 0.2× 16 0.1× 55 0.6× 24 0.4× 15 0.3× 24 163
Sanford Katz United States 12 170 0.9× 84 0.7× 86 0.9× 86 1.3× 79 1.6× 25 365
Syed H. Abid United States 3 115 0.6× 40 0.3× 27 0.3× 6 0.1× 10 0.2× 7 262
Krystle A. Lang Kuhs United States 10 18 0.1× 56 0.5× 21 0.2× 21 0.3× 4 0.1× 17 245
Michael Odida Uganda 9 21 0.1× 84 0.7× 102 1.1× 8 0.1× 27 262
Timothy Best United States 7 32 0.2× 55 0.5× 14 0.2× 1 0.0× 6 0.1× 22 200
J. M. Wands United States 13 39 0.2× 48 0.4× 10 0.1× 10 0.1× 14 579
M Nicolosi Italy 8 156 0.8× 82 0.7× 48 0.5× 2 0.0× 1 0.0× 21 283
Anna Sharman United Kingdom 10 191 1.0× 50 0.4× 46 0.5× 9 0.1× 24 353
Remus Frei Switzerland 8 105 0.6× 72 0.6× 138 1.5× 22 260

Countries citing papers authored by T. Kennedy

Since Specialization
Citations

This map shows the geographic impact of T. Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Kennedy more than expected).

Fields of papers citing papers by T. Kennedy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Kennedy. The network helps show where T. Kennedy may publish in the future.

Co-authorship network of co-authors of T. Kennedy

This figure shows the co-authorship network connecting the top 25 collaborators of T. Kennedy. A scholar is included among the top collaborators of T. Kennedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Kennedy. T. Kennedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Reinemeyer, Craig R., et al.. (2012). Parasitologic, Physiologic, and Performance Parameters of Yearling Horses Receiving Daily Pyrantel Tartrate. Journal of Equine Veterinary Science. 32(10). S40–S40. 1 indexed citations
3.
4.
Akerman, Paul, H. J. Wanebo, Barbara J. Daly, et al.. (2006). Cetuximab, paclitaxel, carboplatin and radiation for esophageal and gastric cancer. Journal of Clinical Oncology. 24(18_suppl). 4029–4029. 15 indexed citations
5.
6.
7.
Iannitti, David A., et al.. (2004). Erlotinib, gemcitabine, paclitaxel and radiation for locally advanced pancreatic cancer: a phase I study. Journal of Clinical Oncology. 22(14_suppl). 4093–4093.
8.
Rathore, Ritesh, Prakash Chougule, H. J. Wanebo, et al.. (2004). Phase I/II study of induction weekly paclitaxel, ifosfamide and carboplatin (PIC) followed by chemoradiotherapy (CRT) in advanced head and neck squamous cell cancers (HN-SCC). Journal of Clinical Oncology. 22(14_suppl). 5602–5602. 1 indexed citations
9.
Iannitti, David A., Thomas A. DiPetrillo, Nicklas B.E. Oldenburg, et al.. (2004). Erlotinib, gemcitabine, paclitaxel and radiation for locally advanced pancreatic cancer: a phase I study. Journal of Clinical Oncology. 22(14_suppl). 4093–4093.
10.
Wanebo, H. J., Prakash Chougule, Neal Ready, et al.. (2001). Surgical Resection Is Necessary To Maximize Tumor Control in Function-Preserving, Aggressive Chemoradiation Protocols for Advanced Squamous Cancer of the Head and Neck (Stage III and IV). Annals of Surgical Oncology. 8(8). 644–650. 47 indexed citations
11.
Furr, Martin & T. Kennedy. (2001). Cerebrospinal fluid and serum concentrations of ponazuril in horses.. PubMed. 2(3). 232–7. 17 indexed citations
12.
Furr, Martin, T. Kennedy, R. J. MacKay, et al.. (2001). Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis.. PubMed. 2(3). 215–22. 41 indexed citations
13.
Choy, H., Wallace Akerley, Howard Safran, et al.. (1998). Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 16(10). 3316–3322. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui Yuan Breakdown of academic impact, for papers by Sanford Katz Breakdown of academic impact, for papers by Syed H. Abid Breakdown of academic impact, for papers by Krystle A. Lang Kuhs Breakdown of academic impact, for papers by Michael Odida Breakdown of academic impact, for papers by Timothy Best Breakdown of academic impact, for papers by J. M. Wands Breakdown of academic impact, for papers by M Nicolosi Breakdown of academic impact, for papers by Anna Sharman Breakdown of academic impact, for papers by Remus Frei
Rankless by CCL
2026